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The class III NAD+ dependent deacetylases-sirtuins (SIRTs) link transcriptional regulation
to DNA damage response and reactive oxygen species generation thereby modulating
a wide range of cellular signaling pathways. Here, the contribution of SIRT1, SIRT3,
and SIRT5 in the regulation of cellular fate through autophagy was investigated under
diverse types of stress. The effects of sirtuins’ silencing on cell survival and autophagy
was followed in human osteosarcoma and mesothelioma cells exposed to DNA damage
and oxidative stress. Our results suggest that the mitochondrial sirtuins SIRT3 and 5
are pro-proliferative under certain cellular stress conditions and this effect correlates with
their role as positive regulators of autophagy. SIRT1 has more complex role which is
cell type specific and can affect autophagy in both positive and negative ways. The
mitochondrial sirtuins (SIRT3 and SIRT5) affect both early and late stages of autophagy,
whereas SIRT1 acts mostly at later stages of the autophagic process. Investigation of
potential crosstalk between SIRT1, SIRT3, and SIRT5 revealed several feedback loops
and a significant role of SIRT5 in regulating SIRT3 and SIRT1. Results presented here
support the notion that sirtuin family members play important as well as differential roles
in the regulation of autophagy in osteosarcoma vs. mesothelioma cells exposed to DNA
damage and oxidative stress, and this can be exploited in increasing the response of
cancer cells to chemotherapy.
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INTRODUCTION
Sirtuins are a family of seven proteins (SIRT1–7) of which
some members exert histone deacetylase (HDAC) and/or
ADP ribosyltransferase (ART) activity (1) or mediate other
posttranslational modifications such as desuccinylation,
demalonylation, and deglutarylation (2). The distinguishing
characteristic of sirtuins is that in contrast to the members of the
other HDAC classes (I, II, and IV) the class III members depend
on the presence of increased levels of the oxidized nicotinamide
adenine dinucleotide (NAD+) (3), which links their function
to cellular energy pathways, and the regulation of oxidative
stress (4, 5).
Sirtuin family members modulate transcription and the
cellular redox state (6–8) and by doing so they orchestrate the
outcome of a variety of cellular functions including autophagy,
apoptosis, cell cycle control, response to DNA damage, and
other signaling cascades (9–13). In particular, SIRT1 participates
in nuclear DNA damage repair by regulating the PARP1
activity and in mitochondrial homeostasis through deacetylating
PGC1α as well as participating in other pathways (14). The
mitochondrial SIRT3 regulates nuclear-mitochondrial crosstalk
in response to DNA damage, is involved in Ku70-dependent
DNA damage repair (15), the generation of reactive oxygen
species in mitochondria and in the mtDNA damage repair (16).
Depending on the type of cancer SIRT5 has been reported to act
as both oncogene (17) and tumor suppressor (18). The role of
SIRT5 in DNA damage response is not well-studied but some
literature suggests its potential function in ammonia-induced
autophagy and mitophagy (19). SIRT5 promotes resistance to
drugs inducing DNA damage in Non-Small Cell Lung Cancer
(NSCLC), suggesting its potential as therapeutic target (20).
Sirtuins are important regulators of the evolutionarily
conserved degradative autophagy process affecting this pathway
in several different ways (21, 22). It has been reported that there
is simultaneous regulation of SIRT1 and autophagy (23) and
induction of SIRT1 by caloric restriction (CR) (24). Autophagy
plays dual role as it both promotes cell survival (25, 26) and cell
death (27), depending on the cell type, the type of stress, and
the extent of damage. Some aspects of the role of SIRT1 in cell
fate control in osteosaroma (28) and mesothelioma (29, 30) have
been described as well as increased response to chemotherapy
upon inhibition of autophagy in mesothelioma (31) but the role
of the other sirtuin family members in autophagy and response to
drug treatment in osteosarcoma and mesothelioma has not been
clearly elucidated.
In the present study, the effects of different sirtuin family
members on autophagy, the cell type or disease specificity of
these effects, as well as the possibility to increase the therapeutic
response to chemotherapy by targeting different sirtuins family
members was investigated in osteosarcoma and mesothelioma
cell lines. The results reported here suggest that in U2OS cells
SIRT1 induced opposite pathways than SIRT3 and SIRT5, leading
to cell death (SIRT1) or cell survival (SIRT3 and SIRT5) in
response to DNA damage. In mesothelioma cell lines, SIRT3 and
SIRT5 exerted pro-survival trends. These effects can in part be
explained by the differential and selective control of autophagy by
sirtuin family members and crosstalk between individual sirtuin
family members.
MATERIALS AND METHODS
Cell Lines, Cell Culture, and Constructs
U2OS, Mero-14, and REN cells were cultured in DMEM (Sigma
Aldrich, UK) supplemented with 10% heat inactivated fetal calf
serum (Gibco, UK) and 1% of penicillin and streptomycin 10,000
U/ml (Sigma Aldrich, UK) at 37◦C in a humidified atmosphere
containing 5% CO2. Wherever mentioned, cells were treated
with 10µM of the mitochondrial respiratory chain complex I
inhibitor rotenone (32), the topoisomerase II inhibitor etoposide
(33) (Sigma Aldrich, UK) or the SIRT1 and autophagy modulator
resveratrol (Enzo Life Sciences, NY, USA) for 24 h.
The Flag-SIRT1 and SIRT3 expression constructs (34) were
purchased from Addgene (Middlesex, UK) (35), and the SIRT5
was obtained from Dr. Chua (Stanford University School of
Medicine, Stanford) (36). The polyfect transfection system
(Qiagen, UK) was used to transfect cells according to the
manufacturer’s instructions.
Sulforhodamine B (SRB) Assay
Transfection of siRNA against SIRT1, SIRT3, SIRT5, and non-
targeting siRNA was carried out in 5 × 103 cells/well in 96-
well plates for 48 h. Transfected cells were treated with DMSO
or the drugs, rotenone, etoposide, and resveratrol with various
concentrations as indicated for 48 h. After treatment, cells were
fixed with 10% trichloroacetic acid (TCA) for 1 h and then
dried overnight at room temperature. Cells were stained with
SRB dye for 15min, washed twice with 1% acetic acid, and air
dried for at least 1 h. The incorporated dye was dissolved in
10mM Tris pH 8.8 solution and then plate was analyzed using
a colorimetric microplate reader (Thermo Electron Multiskan
Ascent Microplate Reader) (Akribis Scientific, Knutsford, UK).
Immunoblotting and Antibodies
Cells were harvested in high salt lysis buffer (45mM HEPES
pH 7.5, 400mM NaCl, 1mM EDTA, 10% glycerol, 0.5% NP-40,
1mM DTT, 1mM PMSF, protease inhibitors including 1µg/ml
aprotinin, 1µg/ml leupeptin, 1µg/ml pepstatin, phosphatase
inhibitors including 20mM β-glycerophosphate, 5mM sodium
pyrophosphate, and 2mM sodium orthovanadate) and equal
amounts of protein were loaded and resolved by SDS-PAGE
and Western blotting. The specific primary antibodies for β-
Actin (Abcam), Beclin-1 (Cell Signaling), LC3 (Cell Signaling),
SIRT1 (B-7, Santa Cruz Biotechnology), SIRT3 (C73E3, Cell
Signaling), SIRT5 (D5E11, Cell Signaling), and anti-Flag M2
(Sigma Aldrich) were diluted 1:2,000 in 5% skimmed milk in
Tris-buffered saline-Tween (TBS-T). Secondary antibodies were
diluted 1:1,000 and incubated for 1 h. Blots were developed with
ECL substrate according to manufacturer’s instructions (Pierce,
Thermo Scientific, USA).
Quantitative RT-PCR
Quantitative RT-PCR analysis was carried out as described
previously (37). Briefly, total RNA was extracted from cells
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using RNeasy plus mini kit (74134, Qiagen, USA) following
manufacturer’s instructions. The RNA was then reverse
transcribed to cDNA (BIO-65042, Bioline cDNA synthesis kit)
and used for qRT-PCR analysis using SYBR Green fluorescent
probe. Specific primers for LC3 were used to perform qRT-
PCR and analysis of the results was carried out using the
OpticonMonitor 3.1 software. All values were normalized to
the RPL-19 control. The primer sequences used in qRT-PCR
reaction are provided in Supplementary Table 1.
Small Interfering RNA
Cells were transfected with siRNA against SIRT1, SIRT3,
SIRT5, and non-targeting siRNA was used as a control.
siRNAs were transfected with DharmaFECT(# T-2001) according
to the manufacturer’s (GE Dharmacon) instructions. Cells
were maintained in 10% FBS DMEM 48 h after transfection.
The siRNA sequences targeting SIRT1, SIRT3, SIRT5, and
the non-targeting scramble siRNAs are provided in the
Supplementary Table 2.
GFP-LC3 Punctate Assay
Cells were transfected with siRNA against SIRT1, SIRT3, SIRT5,
non-targeting siRNA, and GFP-LC3 plasmid (Addgene, # 24920)
using Lipofectamine 2000 reagent (Thermo Fisher Scientific) for
24 h. After that, 10µM rotenone, 10µM etoposide, and 50µM
resveratrol were used to treat the cells for 24 h. Cells were
collected and analyzed using BD FACSVerseTM Flow Cytometer
(BD Biosciences). The reduction of the GFP-LC3 mean
fluorescence intensity is an indicator of autophagy activation.
Flow Cytometric Analysis of Autophagy
FACS analysis and the monodansylcadaverine (MDC) that
preferentially accumulates in autophagic vacuoles were used
(38–41) to assess autophagy. U2OS cells were cultured for
24 h in 6-well plates. The cells were treated with rotenone
and etoposide for 24 h. The collected cells were suspended
in 0.05mM autophagy vacuole specific dye MDC at 37◦C
for 10min (42). For experiments where cells were transiently
transfected, CD20 expressing vector was co-transfected with
other plasmids and used as an indicator of transfection efficiency.
CD20 expresses the B-lymphocyte antigen CD20. Exogenously
introduced CD20 is delivered on cell surface which is tagged by
APC-H7 conjugated CD20 IgG antibody. After dissociation cells
were incubated with 1ml of APC-H7 conjugated CD20 antibody
(1µg/ml, 1:1,000, BD Biosciences) in cell culture medium on
a rotator at room temperature for 1 h. Population of cells that
retained APC-H7 fluorescence emission were selected for MDC
measurement. Then cells were analyzed with flow cytometer
(Becton Dickinson). The fluorescent intensity of intracellular
MDC reflected the number of autophagic cells.
Statistical Analysis
Statistical analysis was performed using GraphPad software.
Error bars represent standard error of means. One-way analysis
of variance (ANOVA) and Tukey’s multiple comparisons post-
test were used for the analysis of the data. p values lower or equal
to 0.05 were considered statistically significant.
RESULTS
Effect of SIRT Family Members on Drug
Cytotoxicity
Given the role of the sirtuin family members in regulating
vital cellular functions the contribution of individual sirtuin
family members to cell survival was investigated. The effects
of silencing of the nuclear SIRT1 vs. the mitochondrial SIRT3
and SIRT5 family members on cell viability were analyzed
in the human osteosarcoma (U2OS) and mesothelioma
(Mero-14 and REN) cell lines. Cells were treated with the
mitochondrial respiratory chain complex I inhibitor rotenone
(32) to test effects of oxidative stress, the topoisomerase
II inhibitor etoposide (33) to analyse effects of DNA
damage and the sirtuins activator and autophagy modulator
resveratrol (43).
In scramble siRNA transfected U2OS and REN cells, all drug
treatments decreased cell viability, whereas in scramble siRNA
transfected Mero-14 cells only rotenone and etoposide and not
resveratrol reduced cell survival (Figure 1). Silencing of the
nuclear SIRT1 significantly increased cell viability in U2OS cells
(Figure 1A, compare bars 1–6 to 7–12), whereas silencing of
the mitochondrial SIRT3 and SIRT5 did not affect cell survival
in the absence of treatment (Figure 1A, compare bar 1 to bars
13 and 19, respectively). SIRT1 silencing in U2OS cells treated
with rotenone, etoposide, and resveratrol resulted in significant
increase of cell viability compared to scramble transfected cells
treated with the same drugs (Figure 1A, compare bars 2–6 to 8–
12). On the contrary, silencing of the mitochondrial SIRT3 and
SIRT5 in U2OS cells led to decreased cell viability upon etoposide
treatment (Figure 1A, compare bars 3, 4 to 15, 16 and 21, 22
respectively). In addition, reduced cell viability was observed in
resveratrol treated U2OS cells transfected with siRNA targeting
SIRT3 (Figure 1A, compare bar 6 to 18).
To determine whether the observed effects of sirtuin family
members on cell viability in U2OS cells were similar in
other types of cancer, SRB assay was carried out in Mero-14
mesothelioma cells transfected either with scramble or siRNA
targeting SIRT1, SIRT3, or SIRT5. Silencing of the nuclear
SIRT1 and the mitochondrial SIRT3 and SIRT5 did not affect
significantly cell viability in Mero-14 cells in the absence of any
treatment (Figure 1B, compare bar 1 to 7, 13, and 19). SIRT1
or SIRT5 silencing in Mero-14 cells did not affect significantly
cell viability in the presence of rotenone, etoposide or resveratrol
(Figure 1B, compare bars 1–6 to 7–12 and 19–24). In contrast,
significantly decreased cell viability was evident in Mero-14
cells transfected with siRNA targeting SIRT3 and treated with
resveratrol (Figure 1B, compare bar 6 to 18).
The effects of silencing of sirtuin family members on cell
viability were also tested in the REN cell line which differs from
Mero-14 in terms of expression of crucial genes involved in
cancer cell viability and response to cytotoxic drugs including p53
(44, 45). Substantial and statistically significant downregulation
of cell viability was observed in REN cells treated with the studied
drugs, however silencing of SIRT1, SIRT3, and SIRT5 did not
exert significant effects (Figure 1C) although downward trend
was observed in SIRT3 and SIRT5 silenced cells.
Frontiers in Oncology | www.frontiersin.org 3 September 2019 | Volume 9 | Article 949
Garva et al. Autophagy Regulation by Sirtuin Family
FIGURE 1 | Effect of silencing of sirtuin family members on cancer cell viability under diverse types of cellular stress. SRB assay was used to assess cell viability of (A)
U2OS, (B) Mero-14, and (C) REN cells in which SIRT1 (7–12), SIRT3 (13–18), or SIRT5 (19–24) had been transfected to silence the respective sirtuin family member
as indicated. Cells were treated with rotenone, etoposide, and resveratrol for 48 h with the indicated concentrations. Bars 1–6 represent cell viability of cells
transfected with siRNA scramble. Error bars represent standard error of means of three or more independent experiments. One-way analysis of variance (ANOVA) and
Tukey’s multiple comparisons post-test were used for the analysis of the data. p < 0.05 was considered to be statistically significant. p < 0.001 is indicated with (*),
p < 0.01 with (#), and p < 0.05 with ($).
In summary, silencing of SIRT1 led to increased U2OS cell
viability in all conditions tested and SIRT5 silencing resulted in
decreased cell viability in etoposide treated U2OS cells. SIRT3
and SIRT5 exerted opposing to SIRT1 effects on cell viability
of U2OS cells exposed to diverse types of cellular stress (pro-
survival the SIRT3 and SIRT5 and pro-death the SIRT1). Reduced
cell viability was also observed in mesothelioma cells treated with
rotenone and etoposide, as well as in resveratrol treated Mero-14
cells in which SIRT3 had been silenced.
Inter-family Regulation of SIRT Family
Members
To investigate potential interdependency between individual
family members, the protein levels of SIRT1, SIRT3, and SIRT5
were determined in U2OS, Mero-14, and REN cells in which
each one of these sirtuin family members had been silenced.
In U2OS cells, SIRT1 silencing increased SIRT3 protein levels
in rotenone treated cells (Figure 2Aii, compare bars 2 and 6)
and SIRT5 protein levels in etoposide treated cells (Figure 2Aiii,
compare bar 3 to 7). In Mero-14 cells, SIRT1 silencing decreased
SIRT3 protein levels in rotenone and etoposide treated cells
(Figure 2Bii, compare bars 2 and 3 with bars 6 and 7). In REN
cells, SIRT1 silencing increased SIRT3 protein levels in rotenone
treated cells (Figure 2Cii, compare bar 2 to 6) and SIRT5 protein
levels in etoposide and resveratrol treated cells (Figure 2Ciii,
compare bars 3 and 4 to 7 and 8). In U2OS cells, SIRT3 silencing
increased SIRT5 protein levels in untreated and rotenone treated
cells (Figure 3Aiii, compare bars 1 and 2 to 5 and 6). In
Mero-14 cells, SIRT3 silencing increased SIRT1 protein levels in
untreated cells (Figure 3Bi, compare bar 1 to 5) and decreased
SIRT5 protein levels in etoposide and resveratrol treated cells
(Figure 3Biii, compare bars 3 and 4 to 7 and 8). Silencing of
SIRT3 had no major effect in REN cells (Figure 3C). In U2OS
cells, SIRT5 silencing resulted in downregulation of SIRT1 and
SIRT3 protein levels (Figures 4Ai,ii, compare bars 1 to 5). In
Mero-14 cells, SIRT5 silencing increased SIRT1 levels in the
untreated and resveratrol treated cells and SIRT3 protein levels in
resveratrol treated cells (Figures 4Bi,ii, compare bars 1 to 5 and 4
to 8, respectively). In REN cells, SIRT5 silencing decreased SIRT3
protein levels in untreated, rotenone, and etoposide treated cells
(Figure 4Cii, compare bars 1, 2, and 3 to 5, 6, and 7).
In summary, complex interactions between SIRT1, SIRT3, and
SIRT5 were identified, that changed upon oxidative stress and
DNA damage. The majority of the feedback loops originated
from SIRT5.
Effect of SIRT Family Members on Beclin-1
and LC3 Autophagy Markers
In the next set of experiments, effects of sirtuin family members
on autophagy markers beclin-1 and LC3 were followed in U2OS
human osteosarcoma cells, Mero-14 and REN mesothelioma
cells. U2OS cells were incubated in HBSS as positive control
to mimic starvation and confirm beclin-1 and LC3II/LC3I
increase under these conditions (Supplementary Figure 1).
SIRT1 silencing resulted in the downregulation of beclin-1
protein levels in U2OS cells treated with resveratrol (Figure 5Ai,
compare bars 4 and 8). Down regulation of LC3II/LC3I ratio
was observed in untreated U2OS cells in which SIRT1 had
been silenced (Figure 5Aii, compare bar 1 to 5). In SIRT1
silenced Mero-14 cells, the LC3II/LC3I ratio was downregulated
in rotenone treated cells (Figure 5Bii, compare bar 2 to 6).
In REN cells carrying silenced SIRT1, the LC3II/LC3I ratio
was upregulated in etoposide and resveratrol treated cells
(Figure 5Cii, compare bars 3 and 4 to 7 and 8).
SIRT3 silencing led to downregulation of beclin-1 in U2OS
cells treated with rotenone and etoposide (Figure 6Ai, compare
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FIGURE 2 | Effect of silencing of SIRT1 on SIRT3 and on SIRT5 protein levels. Protein levels of SIRT1, SIRT3, and SIRT5 were determined by SDS PAGE followed by
Western blot. Silencing of SIRT1 gene expression in (A) U2OS, (B) Mero-14, and (C) REN cells. Protein levels were analyzed using antibodies specific for the SIRT1,
SIRT3, or SIRT5. Actin was used as a loading control. Representative western blot is shown. Image J was used for quantification. Values are normalized to actin and
then to control. Error bars represent standard error of the mean of three independent experiments. One-way analysis of variance (ANOVA) and Tukey’s multiple
comparisons post-test were used for the analysis of data. p < 0.05 was considered to be statistically significant. p < 0.001 is indicated with (***), p < 0.01 with (**),
and p < 0.05 with (*).
bars 2 and 3 to 6 and 7). SIRT3 silencing down regulated the
LC3II/LC3I ratio in untreated U2OS cells (Figure 6Aii, compare
bar 1 to 5), whereas upregulation of this ratio was observed
in the resveratrol treated SIRT3 silenced cells (Figure 6Aii,
compare bar 4 to 8). In Mero-14 cells, in which SIRT3 had been
silenced beclin-1 protein levels were downregulated in resveratrol
treated cells (Figure 6Bi, compare bar 4 to 8). In Mero-14 cells
bearing silenced SIRT3, the LC3II/LC3I ratio was downregulated
in rotenone treated cells (Figure 6Bii, compare bar 2 to 6).
In REN cells carrying silenced SIRT3 beclin-1 protein levels
were downregulated in etoposide and resveratrol treated cells
(Figure 6Ci, compare bars 3 and 4 to 7 and 8). In SIRT3 silenced
REN cells, the LC3II/LC3I ratio was upregulated in the presence
of resveratrol (Figure 6Cii, compare bar 4 to 8).
Beclin-1 protein levels and LC3II/LC3I ratio were
downregulated in SIRT5 silenced untreated, rotenone, or
etoposide treated U2OS cells (Figures 7Ai,ii, compare bars
1, 2, and 3 to 5, 6, and 7, respectively). In SIRT5 silenced
Mero-14 cells, beclin-1 protein levels were downregulated
upon rotenone and resveratrol treatment (Figure 7Bi, compare
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FIGURE 3 | Effect of silencing of SIRT3 on SIRT1 and on SIRT5 protein levels. Protein levels of SIRT1, SIRT3, and SIRT5 were determined by SDS PAGE followed by
Western blot. Silencing of SIRT3 gene expression in (A) U2OS, (B) Mero-14, and (C) REN cells. Protein levels were analyzed using antibodies specific for the SIRT1,
SIRT3, or SIRT5. Actin was used as a loading control. Representative western blot is shown. Image J was used for quantification. Values are normalized to actin and
then to control. Error bars represent standard error of the mean of three independent experiments. One-way analysis of variance (ANOVA) and Tukey’s multiple
comparisons post-test were used for the analysis of data. p < 0.05 was considered to be statistically significant. p < 0.001 is indicated with (***), p < 0.01 with (**),
and p < 0.05 with (*).
bars 2 and 4 to 6 and 8, respectively). LC3II/LC3I ratio was
upregulated in resveratrol treated Mero-14 cells in which SIRT5
had been silenced (Figure 7Bii, compare bars 4 and 8). In
REN cells, SIRT5 silencing downregulated beclin-1 protein
levels in resveratrol treated cells (Figure 7Ci, compare bar 4 to
8). LC3II/LC3I ratio was downregulated in etoposide treated
REN cells lacking SIRT5 expression (Figure 7Cii, compare
bar 3 to 7).
In summary, in most cases, where significant effects were
detected, SIRT1, SIRT3, and SIRT5 had positive effects on beclin-
1 and LC3II/LC3I ratio, except in REN etoposide treated cells,
where SIRT1 had negative effect on LC3II/LC3I ratio.
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FIGURE 4 | Effect of silencing of SIRT5 on SIRT1 and on SIRT3 protein levels. Protein levels of SIRT1, SIRT3, and SIRT5 were determined by SDS PAGE followed by
Western blot. Silencing of SIRT5 gene expression in (A) U2OS, (B) Mero-14, and (C) REN cells. Protein levels were analyzed using antibodies specific for the SIRT1,
SIRT3, or SIRT5. Actin was used as a loading control. Representative Western blot is shown. Image J was used for quantification. Values are normalized to actin and
then to control. Error bars represent standard error of the mean of three independent experiments. One-way analysis of variance (ANOVA) and Tukey’s multiple
comparisons post-test were used for the analysis of data. p < 0.05 was considered to be statistically significant. p < 0.001 is indicated with (***), p < 0.01 with (**),
and p < 0.05 with (*).
To explore whether the observed outcome of LC3II/LC3I
ratio was a result of sirtuins mediated effects on transcriptional
regulation of LC3, U2OS cells were transfected with SIRT1 or
SIRT5 expression plasmids and total LC3 protein levels were
followed. Ectopically expressed SIRT1 changed marginally but
significantly the total LC3 protein and mRNA levels compared
to pcDNA3 transfected cells (Supplementary Figures 2A–C,
compare lane 1 to 2). SIRT5 overexpression modestly increased
the total LC3 protein levels whereas LC3 mRNA levels did not
change significantly (Supplementary Figures 2D–F, compare
bar 1 to 2). These data provide evidence that SIRT1 and
SIRT5 induce autophagy by inducing LC3 gene expression in
U2OS cells.
Effect of SIRT Family Members on Cellular
Autophagy
Effects of sirtuin family members on autophagy markers beclin-
1 and LC3 documented above indicated that this family plays
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FIGURE 5 | The effect of SIRT1 silencing on LC3 and Beclin-1 protein levels. (A) U2OS, (B) Mero-14, or (C) REN cells were transfected with either scrambled siRNA
or SIRT1 siRNA and treated with rotenone, etoposide, or resveratrol or left untreated as indicated. Protein levels were analyzed using antibodies specific for the LC3
and Beclin-1 autophagy markers. Actin was used as a loading control and LC3II/LC3I ratio was calculated. Representative Western blot is shown. Image J was used
for quantification. Values are normalized to actin and then to control. Error bars represent standard error of the mean of three independent experiments. One-way
analysis of variance (ANOVA) and Tukey’s multiple comparisons post-test were used for the analysis of data. p < 0.05 was considered to be statistically significant.
p < 0.001 is indicated with (***), p < 0.01 with (**), and p < 0.05 with (*).
an important role in autophagy control. To substantiate these
findings, the LC3 punctate analysis was employed using flow
cytometry (Figure 8). In this assay activation of autophagy
should result in a decreased GFP-LC3 signal. Silencing of SIRT1,
SIRT3, or SIRT5 in the absence of drug treatment did not affect
autophagy (Figure 8B, compare bar 1 to 5, 9, and 13). Drug
treatment had selective effect on autophagy in the presence
and absence of individual sirtuins. Rotenone, etoposide, and
resveratrol decreased autophagy in scramble siRNA transfected,
as was evident by the increased LC3-GFP signal (Figure 8B,
compare bar 1 to 2, 3 and 4). When SIRT1 was silenced, drug
treatment did not affect autophagy substantially compared to the
respective scramble control (Figure 8B, compare bars 2, 3, and
4 to 6, 7, and 8, respectively). SIRT3 silencing led to inhibition
of autophagy in U2OS cells treated with etoposide or resveratrol
(Figure 8B, compare bars 3 and 4 to 11 and 12), whereas SIRT5
silencing resulted in inhibition of autophagy in resveratrol treated
U2OS cells (Figure 8B, compare bar 4 to 16). These results were
confirmed by an additional assay assessing autophagy (MDC)
(Supplementary Figure 3). Overexpression of sirtuins 3 and 5 in
U2OS cells increased autophagy in both the absence and presence
of rotenone and etoposide. Results shown in Figure 8 suggest
that the individual sirtuins differentially modified drug effect
on the autophagy process. SIRT1 had marginal effect on drug
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FIGURE 6 | The effect of SIRT3 silencing on LC3 and Beclin-1 protein levels. (A) U2OS, (B) Mero-14, or (C) REN cells were transfected with either scrambled siRNA
or SIRT3 siRNA and treated with rotenone, etoposide, or resveratrol or left untreated as indicated. Protein levels were analyzed using antibodies specific for the LC3
and Beclin-1 autophagy markers. Actin was used as a loading control and LC3II/LC3I ratio was calculated. Representative Western blot is shown. Image J was used
for quantification. Values are normalized to actin and then to control. Error bars represent standard error of the mean of three independent experiments. One-way
analysis of variance (ANOVA) and Tukey’s multiple comparisons post-test were used for the analysis of data. p < 0.05 was considered to be statistically significant.
p < 0.001 is indicated with (***), p < 0.01 with (**), and p < 0.05 with (*).
mediated control of autophagy, SIRT3 potentiated the effects of
etoposide and resveratrol, whereas SIRT5 stimulated the effect of
resveratrol on autophagy.
DISCUSSION
Autophagy is a degradative cellular machinery that eliminates
damaged proteins and organelles thus serving as an important
housekeeping pathway (46). One of the mechanisms modifying
autophagy entails individual sirtuin family members. Reports
investigating the role of SIRT1 as regulator of autophagy and
response to cellular stress suggest that its effects are mainly
mediated through its deacetylase activity (24) and can be both
positive and negative (21, 22). SIRT1 knockout mouse embryonic
fibroblasts exhibit decreased autophagy which coincides with
increased levels of acetylated Atg5, Atg7, and LC3 (9). In
osteosarcoma patients high expression of SIRT1 is associated
with poor prognosis suggesting that SIRT1 promotes autophagy
(28). In mesothelioma and lung cancer cells pemetrexed induces
ROS generation and SIRT1 function thereby inducing apoptosis
(28). In addition, SIRT1 has been shown to play a role in mTOR,
AKT, and ER beta signaling in mesothelioma (29, 30). Although,
the role of SIRT3 and SIRT5 in the control of cell fate has not
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FIGURE 7 | The effect of SIRT5 silencing on LC3 and Beclin-1 protein levels. (A) U2OS, (B) Mero-14, or (C) REN cells were transfected with either scrambled siRNA
or SIRT-5 siRNA and treated with rotenone, etoposide, or resveratrol or left untreated as indicated. Protein levels were analyzed using antibodies specific for the LC3
and Beclin-1 autophagy markers. Actin was used as a loading control and LC3II/LC3I ratio was calculated. Representative western blot is shown. Image J was used
for quantification. Values are normalized to actin and then to control. Error bars represent standard error of the mean of three independent experiments. One-way
analysis of variance (ANOVA) and Tukey’s multiple comparisons post-test were used for the analysis of data. p < 0.05 was considered to be statistically significant.
p < 0.001 is indicated with (***), p < 0.01 with (**), and p < 0.05 with (*).
been well-understood it has been shown that SIRT3 knockout
mouse embryonic fibroblast cells exhibit increased autophagy
in response to starvation in an LC3 independent manner (47).
In addition, SIRT3 positively affects autophagy in neuronal cells
and macrophages and exerts negative effect in hepatocytes (48,
49). SIRT5 is a key modulator of the response to starvation,
metabolic homeostasis and cellular survival (50) promoting
autophagy in colorectal cancer and its overexpression in this
cancer is associated with poor survival (51). In breast cancer
and mouse myoblasts cells SIRT5 silencing increases ammonia-
induced autophagy through control of glutamine metabolism
and mitophagy (19). Taken together these observations suggest
that the relative contribution of sirtuin family members to
autophagy is executed by distinct signaling networks which may
depend on their enzymatic activity as deacetylases, cellular stress
signals, and cell type (4). In this study the role of the sirtuins
family members SIRT1, SIRT3, and SIRT5 in the regulation
of autophagy was analyzed in the human osteosarcoma U2OS,
and mesothelioma Mero-14 and REN cells treated with the
inhibitor of the complex I of the mitochondrial respiratory
chain rotenone, the topoisomerase II inhibitor etoposide widely
used in the clinic, and the sirtuins activator and autophagy
modulator resveratrol.
SIRT1 displayed cell type specific effects as it exerted pro-
death activities in osteosarcoma but not in mesothelioma cells
(Figure 1) possibly attributed to selective modulation of beclin-
1 protein levels in U2OS cells (Figure 5). SIRT1 silencing in
U2OS cells led to pro-survival outcome whereas silencing of
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FIGURE 8 | Regulation of autophagy by SIRT family members (GFP-LC3 punctate staining). (A) Histogram indicating the GFP-LC3 levels detected and quantified in
U2OS cells transiently transfected with GFP-LC3 and a plasmid expressing the CD20 surface marker together with either scramble or siRNA targeting SIRT1, SIRT3,
or SIRT5 and treated with rotenone, etoposide, or resveratrol as indicated. (B) Diagram indicating the analysis of the relative GFP-LC3 levels detected in U2OS cells
transiently transfected with GFP-LC3 and a plasmid expressing the CD20 surface marker together with either scramble (1–4) or siRNA targeting SIRT1 (5–8), SIRT3
(9–12), or SIRT5 (13–16). The values obtained using flow cytometry in different conditions were normalized to those obtained from cells transfected with scramble and
treated with DMSO which were arbitrarily set to 100. p < 0.001 is indicated with (***), p < 0.01 with (**), and p < 0.05 with (*).
this sirtuin family member in Mero-14 and REN cells did
not have significant effect. The existence of differential micro-
environmental conditions in osteosarcoma vs. mesothelioma
cells that diversely affect the sirtuin family members mediated
autophagy could be a potential explanation for these results.
SIRT3 and SIRT5 exhibited pro-survival effects in U2OS cells,
whereas in mesothelioma cell lines SIRT3 and SIRT5 exerted
pro-survival trends (Figures 1A–C). These results could explain
published observations indicating no significant improvement
in the osteosarcoma patients treated with combination of
chemotherapeutics including ifosfamide and etoposide, which
have demonstrated activity in osteosarcoma in earlier studies
(52–54). Conflicting roles of SIRT1 have been reported in
osteosarcoma. High expression of SIRT1 was linked to high risk
osteosarcoma patients (55), however, SIRT1 expression has also
been reported to be down-regulated in metastatic osteosarcoma.
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The selective regulation on beclin-1 protein levels exerted by
resveratrol only in mesothelioma and not in osteosarcoma cells
is possibly due to the fact that NAD+/NADH ratio and ROS
generation in the two cell types upon resveratrol treatment are
regulated by different pathways (56).
Analysis of sirtuin family members crosstalk revealed that
SIRT1 has negative effect on SIRT3 and SIRT5 protein levels
in bone cells (Figure 2A) and this depends on the type of
cellular stress, whereas positive effects were recorded in Mero-
14 mesothelioma cells (Figure 2B). In general interdependency
between sirtuin family members indicated that SIRT5 plays the
most important role in regulating SIRT1 and SIRT3 protein
levels in U2OS, Mero-14, and REN cells (Figures 4A–C) and this
needs to be considered when interpreting results of experiments
in which individual sirtuin family members are silenced.
Overexpression of SIRT1 and SIRT5 in U2OS cells showed
marginal positive effects on total LC3 protein and mRNA levels
implying that these sirtuin family members exert their effects
on autophagy through transcriptional and non-transcriptional
pathways. Recent studies have shown that the mitochondrial
desuccinylase and demalonylase activities of SIRT5 regulate
autophagy and mitophagy (50) and a small nuclear fraction of
SIRT5 exist (17) that could be involved in the SIRT5 mediated
transcriptional regulation of autophagic genes (34).
If the effects on beclin-1 are considered early and those on
LC3II/LC3I ratio as late autophagy events our results suggest
that the nuclear SIRT1 acts mostly at late stages of autophagy
and its effects are cell type/signal specific and depending on the
experimental conditions they can be both positive and negative in
the regulation of autophagy and cell survival. The mitochondrial
sirtuins SIRT3 and SIRT5, on the other side, affect both early
and late stages of autophagy are pro-proliferative under certain
cellular stress conditions and their effects correlate with their role
as positive regulators of autophagy.
Results presented in this study may have therapeutic
implications given that SIRT1, SIRT3, and SIRT5 exert distinct
roles in the regulation of autophagy in several cancer cell lines
and therefore selective targeting of these sirtuin family members
could be the basis for development of new strategies to increase
cell response to chemotherapy. However, other factors such
as the contribution of the microenvironmental conditions in
fine tuning the enzymatic activities of sirtuins and hence the
autophagy process require further investigation.
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